XML 43 R28.htm IDEA: XBRL DOCUMENT v3.19.1
Stock Compensation Plans (Tables)
12 Months Ended
Feb. 02, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Common Stock Shares Issued to Non-Employee Directors as Compensation

The following shares of common stock, with the respective fair value, were issued to its non-employee directors as compensation for fiscal 2018, fiscal 2017 and fiscal 2016:

 

 

 

Number of shares of

common stock issued

 

 

Fair value of

common stock issued

 

Fiscal 2018

 

 

48,896

 

 

$

107,605

 

Fiscal 2017

 

 

42,450

 

 

$

96,856

 

Fiscal 2016

 

 

14,509

 

 

$

68,456

 

Employee Stock Plan, 2006 Plan and 2016 Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Stock Option Activity

 

 

 

Number of

Shares

 

 

Weighted-average

exercise price

per option

 

 

Weighted-average

remaining

contractual term

 

Aggregate

intrinsic value

 

Stock Options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding options at beginning of year

 

 

1,195,910

 

 

$

4.80

 

 

 

 

$

21,750

 

Options granted

 

 

153,888

 

 

$

2.48

 

 

 

 

 

-

 

Options canceled or expired

 

 

(387,398

)

 

$

4.67

 

 

 

 

 

2,000

 

Options exercised

 

 

(5,000

)

 

$

1.85

 

 

 

 

 

7,900

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding options at end of year

 

 

957,400

 

 

$

4.50

 

 

5.0 years

 

$

16,878

 

Options exercisable at end of year

 

 

803,512

 

 

$

4.89

 

 

4.2 years

 

$

8,050

 

Vested and expected to vest at end of year

 

 

935,539

 

 

$

4.54

 

 

4.9 years

 

$

16,441

 

Summary of Restricted Stock Activity

The following table summarizes activity for non-vested shares under the plans for fiscal 2018:

 

 

 

Restricted shares

 

 

Restricted Stock Units (1)

 

 

Deferred shares (2)

 

 

Fully-vested

shares (3)

 

 

Total number of shares

 

 

Weighted-average

grant-date

fair value (4)

 

Shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding non-vested shares at beginning of

   year

 

 

36,666

 

 

 

1,048,552

 

 

 

115,457

 

 

 

 

 

 

1,200,675

 

 

$

3.43

 

Shares granted

 

 

30,000

 

 

 

1,057,071

 

 

 

99,300

 

 

 

124,275

 

 

 

1,310,646

 

 

$

2.50

 

Shares vested/issued

 

 

(3,333

)

 

 

(627,220

)

 

 

(10,717

)

 

 

(124,275

)

 

 

(765,545

)

 

$

3.00

 

Shares canceled

 

 

(33,333

)

 

 

(105,775

)

 

 

 

 

 

 

 

 

(139,108

)

 

$

2.81

 

Outstanding non-vested shares at end of year

 

 

30,000

 

 

 

1,372,628

 

 

 

204,040

 

 

 

 

 

 

1,606,668

 

 

$

2.93

 

Vested and expected to vest at end of year

 

 

30,000

 

 

 

1,166,734

 

 

 

204,040

 

 

 

 

 

 

1,400,774

 

 

 

 

 

 

 

(1)

RSU were primarily granted in connection with the partial achievement of performance targets under the 2016-2017 LTIP and time-based awards under the 2018-2020 LTIP, see Note G, Long-Term Incentive Plans.  As a result of net share settlements, of the 627,220 RSUs which vested during fiscal 2018, only 573,094 shares of common stock were issued.    

(2)

The 99,300 shares of deferred stock, with a fair value of approximately $218,198, represent compensation to certain directors in lieu of cash, in accordance with their irrevocable elections.  The shares of deferred stock vest three years from the date of grant or at separation of service, based on the irrevocable election of each director.

(3)

The 124,275 shares of stock, with a fair value of approximately $268,376 to certain directors as compensation in lieu of cash, in accordance with their irrevocable elections.  Directors are required to elect 50% of their quarterly retainer in equity.  Any shares in excess of the minimum required election are issued from the Fourth Amended and Restated Non-Employee Director Stock Purchase Plan (the “Non-Employee Director Compensation Plan”).  

(4)

The fair value of a restricted share, deferred share and fully-vested share is equal to the Company’s closing stock price on the date of grant.